A Phase III of COVID-19 Vaccine EuCorVac-19 in Healthy Adults Aged 18 Years and Older

NCT05603052 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2852

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19

Interventions

BIOLOGICAL: EuCorVac-19
BIOLOGICAL: ChAdOx1 nCoV-19

Sponsor

EuBiologics Co.,Ltd